跳至主要内容
临床试验/NCT02632149
NCT02632149Unknown早期 1 期

The Clinical Research on PINS Vagus Nerve Stimulator for Treatment of Lennox-Gastaut in Children

Beijing Pins Medical Co., Ltd5 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2016年10月最近更新:
适应症

试验速览

阶段
早期 1 期
入组人数
31
试验地点
5
主要终点
Changes in seizure frequency from baseline to the seizure count evaluation period 6 month

研究概览

简要总结

The purpose of this study is to evaluate the clinical effectiveness of PINS vagus nerve stimulatior in children with Lennox-Gastaut Syndrome.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age 3-14 year
  • Lennox - Gastaut syndrome diagnostic standard
  • Regular drug treatment is invalid
  • Antiepileptic drug stability in recent 3 months
  • Good health except epilepsy
  • Patients or his(her) familyscould understand this method and sign the informed consent
  • Patients with good compliance and could complete postoperative follow-up.

排除标准

  • Results of MRI remind epilepsy caused by intracranial space-occupying lesions
  • Had epileptic foci excision surgery or corpus callosum
  • The vagus nerve lesion and damage
  • Tumor, cardiopulmonary anomaly, progressive neurological diseases, asthma, mental disease,peptic ulcer,diabetes Type 1,bad health etc, and other surgical contraindication
  • Participated in other clinical drug test subjects within three months
  • The researchers think that is not suitable for participants'

结局指标

主要结局

Changes in seizure frequency from baseline to the seizure count evaluation period 6 month

时间窗: 6 month of stimulation

次要结局

  • Changes in seizure frequency from baseline to the seizure count evaluation period(1,3,6,months of stimulation)
  • Change from Baseline in the Engel and McHugh description(At 1,3,6 months)
  • Overall WISC Score in Patients from Baseline(Mean change from baseline WISC Overall Score at 1,3,6months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验